Unlock stock picks and a broker-level newsfeed that powers Wall Street.
Stuttgart - Delayed Quote EUR

Daicel Corporation (9DC.SG)

Compare
7.50
-0.05
(-0.66%)
At close: April 4 at 8:32:57 AM GMT+2
Loading Chart for 9DC.SG
  • Previous Close 7.55
  • Open 7.50
  • Bid 7.15 x 100000
  • Ask 7.40 x 100000
  • Day's Range 7.50 - 7.50
  • 52 Week Range 6.75 - 9.55
  • Volume 70
  • Avg. Volume 17
  • Market Cap (intraday) 2.017B
  • Beta (5Y Monthly) --
  • PE Ratio (TTM) 6.00
  • EPS (TTM) 1.25
  • Earnings Date May 7, 2025 - May 12, 2025
  • Forward Dividend & Yield 0.37 (4.91%)
  • Ex-Dividend Date Mar 28, 2025
  • 1y Target Est --

Daicel Corporation engages in the materials, medical/healthcare, smart, safety, engineering plastics, and other businesses in Japan, China, and internationally. The company offers acetic acid, acetic acid derivative chemicals, acetate tow, acetic anhydride, thioglycolic acid, caprolactone derivatives, methyl 3-methoxyacrylate, cycloaliphatic epoxies, alkylamines comprising diethylhydroxyamine, and 1,3-butylene glycol, as well as cellulose acetate; and Actranza Lab, a drug delivery device. It also provides solutions for the electronics market, such as functional films and materials for use in smartphones, PCs, TVs, and in-vehicle displays; polymers and solvents for use in the semiconductor manufacturing process; optical lenses for use in VR, smartphones, and various sensors; printed electronic materials; and organic semiconductors. In addition, the company offers automobile airbags inflators comprising gas generation devices; pyro-fuses as safety systems for use in products, such as electric vehicles, renewable energy storage, and transmission systems and robots; and gas generators for seat belt pretensioners, as well as engineering plastics and plastic compound products, high performance polymer, functional sheets, formed trays, and packaging films. Further, it reuses water for medical care, drinking water, food, and wastewater fields; and provides chiral columns, chiral reagents, pharma excipients, bellocea S7, flavocell(S-equol), konjac ceramide, polyglycerols, urolithin A, and excipients for food, as well as analytical and separation services. The company's products are used in transportation, electronics, medical care, personal care, everyday life, and environment and energy applications. The company was formerly known as Daicel Chemical Industries, Ltd. and changed its name to Daicel Corporation in October 2011. Daicel Corporation was incorporated in 1919 and is headquartered in Osaka, Japan.

www.daicel.com

11,134

Full Time Employees

March 31

Fiscal Year Ends

Recent News: 9DC.SG

View More

Performance Overview: 9DC.SG

Trailing total returns as of 4/4/2025, which may include dividends or other distributions. Benchmark is Nikkei 225 (^N225) .

YTD Return

9DC.SG
135.30%
Nikkei 225 (^N225)
15.33%

1-Year Return

9DC.SG
84.29%
Nikkei 225 (^N225)
15.07%

3-Year Return

9DC.SG
98.27%
Nikkei 225 (^N225)
21.79%

5-Year Return

9DC.SG
99.66%
Nikkei 225 (^N225)
89.56%

Compare To: 9DC.SG

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: 9DC.SG

View More

Valuation Measures

Annual
As of 4/3/2025
  • Market Cap

    2.03B

  • Enterprise Value

    3.46B

  • Trailing P/E

    6.02

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    0.58

  • Price/Book (mrq)

    0.85

  • Enterprise Value/Revenue

    0.97

  • Enterprise Value/EBITDA

    7.32

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    9.66%

  • Return on Assets (ttm)

    4.59%

  • Return on Equity (ttm)

    15.33%

  • Revenue (ttm)

    576.33B

  • Net Income Avi to Common (ttm)

    55.67B

  • Diluted EPS (ttm)

    1.25

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    78.86B

  • Total Debt/Equity (mrq)

    78.35%

  • Levered Free Cash Flow (ttm)

    --

Research Analysis: 9DC.SG

View More

Company Insights: 9DC.SG

Research Reports: 9DC.SG

View More

People Also Watch